{"slideshow_credits": null, "snippet": "A rule expected from the Food and Drug Administration would allow generic drug makers to update safety labels, a step that could pave the way for the companies to be sued if their drugs harmed users.", "abstract": "Food and Drug Administration signals its intention to permit generic drug makers to make changes to their safety labels; move could open the door to lawsuits against generic drug companies for the first time since Supreme Court decision barred such suits in 2011.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/07/04/business/fda-rule-could-open-generic-drug-makers-to-suits.html", "lead_paragraph": "A rule expected from the Food and Drug Administration would allow generic drug makers to update safety labels, a step that could pave the way for the companies to be sued if their drugs harmed users.", "headline": {"main": "F.D.A. Rule Could Open Generic Drug Makers to Suits", "print_headline": "F.D.A. Rule Could Open Generic Drug Makers to Suits"}, "_id": "51d4c5cb7e0d9c0839d2de50", "word_count": "583", "multimedia": [{"height": 126, "url": "images/2013/07/04/business/Generic/Generic-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/07/04/business/Generic/Generic-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 390, "url": "images/2013/07/04/business/Generic/Generic-articleLarge.jpg", "legacy": {"xlarge": "images/2013/07/04/business/Generic/Generic-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "390"}, "subtype": "xlarge", "width": 600, "type": "image"}], "pub_date": "2013-07-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Generic Pharmaceutical Assn", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Supreme Court", "name": "organizations", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}